The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial.

Published in:

2019

By:

• Schmader, Kenneth E;
• Levin, Myron J;
• Grupping, Katrijn;
• Matthews, Sean;
• Butuk, David;
• Chen, Michael;
• Idrissi, Mohamed El;
• Fissette, Laurence A;
• Fogarty, Charles;
• Hartley, Paul;
• Klein, Nicola P;
• Nevarez, Max;
• Uusinarkaus, Kari;
• Oostvogels, Lidia;
• Curran, Desmond;
• El Idrissi, Mohamed

Publication type:

journal article